Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Beam Therapeutics Inc (BEAM)

Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025 Dec, 2024
Sales 114,110 9,700 8,470 7,470 30,070
Sales Growth +1,076.39% +14.52% +13.39% -75.16% +110.72%
Net Income 244,300 -112,730 -102,290 -109,270 -90,350
Net Income Growth +316.71% -10.21% +6.39% -20.94% +6.54%

Balance Sheet

(Values in U.S. Thousands) Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025 Dec, 2024
Total Assets 1,481,180 1,311,080 1,391,160 1,466,920 1,103,820
Total Assets Growth +12.97% -5.76% -5.16% +32.89% -5.77%
Total Liabilities 242,820 345,080 344,340 343,780 370,280
Total Liabilities Growth -29.63% +0.21% +0.16% -7.16% -2.57%

Cash Flow

(Values in U.S. Thousands) Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025 Dec, 2024
Operating Cash Flow -345,100 -261,810 -180,330 -103,880 -347,250
Operating Cash Flow Growth -31.81% -45.18% -73.59% +70.09% -28.19%
Net Cash Flow 11,510 -15,500 -1,350 244,410 -154,500
Change in Net Cash Flow +174.26% -1,048.15% -100.55% +258.19% +25.67%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.